Investing.com - Merck reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck announced earnings per share of €1.50 on revenue of €4.37B. Analysts polled by Investing.com anticipated EPS of €1.44 on revenue of €4.18B. That with comparison to EPS of €1.13 on revenue of €3.75B in the same period a year before.Merck had reported EPS of €1.54 on revenue of €4.38B in the previous quarter.Analysts are expecting EPS of €1.38 and revenue of €4.16B in the upcoming quarter.
Merck shares are down 39% from the beginning of the year and are trading at €103.17 , down-from-52-week-high.They are under-performing the STOXX 600 which is down 21.56% year to date.
Merck follows other major Healthcare sector earnings this month
Merck's report follows an earnings beat by Siemens AG on May 8, who reported EPS of €1.16 on revenue of €14.23B, compared to forecasts EPS of €0.99 on revenue of €20.63B.
Bayer had beat expectations on April 27 with first quarter EPS of €2.67 on revenue of €12.85B, compared to forecast for EPS of €2.52 on revenue of €12.57B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar